PARAGON 28 INC. news, videos and press releases
For more news please use our advanced search feature.
PARAGON 28 INC. - More news...
PARAGON 28 INC. - More news...
- Paragon 28 to Showcase Recent Product Launches at The American College of Foot and Ankle Surgeons Annual Conference
- Paragon 28 to Feature Several Recent Product Launches at The American Academy of Orthopaedic Surgeons Annual Conference
- Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024
- Paragon 28 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Paragon 28 Appoints Dave Demski to Board of Directors
- ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Paragon 28
- Paragon 28 to Present at the 36th Annual Piper Sandler Healthcare Conference
- Paragon 28 Reports Third Quarter 2024 Financial Results and Raises 2024 Net Revenue Guidance
- Shareholders Invited To Join Paragon 28, Inc. Securities Fraud Investigation With The Schall Law Firm
- Investors Have The Chance To Join The Schall Law Firm's Securities Fraud Investigation Into Paragon 28 Inc
- Paragon 28 Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
- Paragon 28 to Present at the Canaccord Genuity 43rd Annual Growth Conference
- Paragon 28 To Report Second Quarter Financial Results on August 2, 2023
- Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System
- Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
- Paragon 28 to Present at the Bank of America Securities 2023 Healthcare Conference
- Paragon 28 Launches Phantom® Metatarsal Shortening System
- Paragon 28 To Report First Quarter Financial Results on May 4, 2023
- Paragon 28 Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance
- Paragon 28 to Present at Upcoming Investor Conferences
- Paragon 28, Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
- Paragon 28 To Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
- Paragon 28, Inc. Announces Pricing of Public Offering
- Paragon 28, Inc. Announces Proposed Public Offering of Common Stock
- Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
- Paragon 28 to Present at The 34th Annual Piper Sandler Healthcare Conference
- Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
- Paragon 28 To Report Third Quarter 2022 Financial Results on November 10, 2022
